vs

Side-by-side financial comparison of Healthpeak Properties (DOC) and UNIVERSAL INSURANCE HOLDINGS, INC. (UVE). Click either name above to swap in a different company.

Healthpeak Properties is the larger business by last-quarter revenue ($719.4M vs $393.6M, roughly 1.8× UNIVERSAL INSURANCE HOLDINGS, INC.). Healthpeak Properties runs the higher net margin — 73.2% vs 13.8%, a 59.4% gap on every dollar of revenue. On growth, Healthpeak Properties posted the faster year-over-year revenue change (3.1% vs -0.3%). Over the past eight quarters, Healthpeak Properties's revenue compounded faster (8.9% CAGR vs 1.7%).

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

New York Life Insurance Company (NYLIC), most commonly known as New York Life, is the second-largest life insurance company and the largest mutual life insurance company in the United States, and is ranked #69 on the 2025 Fortune 500 list of the largest U.S. corporations by total revenue. In 2025, NYLIC achieved the best possible ratings by the four independent rating companies. Other New York Life affiliates provide an array of securities products and services, as well as institutional and r...

DOC vs UVE — Head-to-Head

Bigger by revenue
DOC
DOC
1.8× larger
DOC
$719.4M
$393.6M
UVE
Growing faster (revenue YoY)
DOC
DOC
+3.4% gap
DOC
3.1%
-0.3%
UVE
Higher net margin
DOC
DOC
59.4% more per $
DOC
73.2%
13.8%
UVE
Faster 2-yr revenue CAGR
DOC
DOC
Annualised
DOC
8.9%
1.7%
UVE

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
DOC
DOC
UVE
UVE
Revenue
$719.4M
$393.6M
Net Profit
$114.0M
$54.3M
Gross Margin
Operating Margin
17.4%
Net Margin
73.2%
13.8%
Revenue YoY
3.1%
-0.3%
Net Profit YoY
2406.4%
EPS (diluted)
$0.16
$1.88

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DOC
DOC
UVE
UVE
Q1 26
$393.6M
Q4 25
$719.4M
$407.9M
Q3 25
$705.9M
$401.0M
Q2 25
$694.3M
$400.1M
Q1 25
$702.9M
$394.9M
Q4 24
$698.0M
$384.8M
Q3 24
$700.4M
$387.6M
Q2 24
$695.5M
$380.2M
Net Profit
DOC
DOC
UVE
UVE
Q1 26
$54.3M
Q4 25
$114.0M
$66.6M
Q3 25
$-117.1M
$39.8M
Q2 25
$31.7M
$35.1M
Q1 25
$42.8M
$41.4M
Q4 24
$4.5M
$6.0M
Q3 24
$85.9M
$-16.2M
Q2 24
$146.0M
$35.4M
Gross Margin
DOC
DOC
UVE
UVE
Q1 26
Q4 25
Q3 25
58.6%
Q2 25
60.2%
Q1 25
61.1%
Q4 24
60.3%
Q3 24
60.0%
Q2 24
60.6%
Operating Margin
DOC
DOC
UVE
UVE
Q1 26
Q4 25
17.4%
21.7%
Q3 25
9.2%
13.2%
Q2 25
5.7%
11.6%
Q1 25
7.7%
14.0%
Q4 24
-2.2%
1.9%
Q3 24
14.1%
-4.7%
Q2 24
22.3%
12.6%
Net Margin
DOC
DOC
UVE
UVE
Q1 26
13.8%
Q4 25
73.2%
16.3%
Q3 25
-16.6%
9.9%
Q2 25
4.6%
8.8%
Q1 25
6.1%
10.5%
Q4 24
0.7%
1.6%
Q3 24
12.3%
-4.2%
Q2 24
21.0%
9.3%
EPS (diluted)
DOC
DOC
UVE
UVE
Q1 26
$1.88
Q4 25
$0.16
$2.29
Q3 25
$-0.17
$1.38
Q2 25
$0.05
$1.21
Q1 25
$0.06
$1.44
Q4 24
$0.02
$0.23
Q3 24
$0.12
$-0.57
Q2 24
$0.21
$1.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DOC
DOC
UVE
UVE
Cash + ST InvestmentsLiquidity on hand
$467.5M
$595.8M
Total DebtLower is stronger
$9.8B
Stockholders' EquityBook value
$7.5B
$584.7M
Total Assets
$20.3B
$2.8B
Debt / EquityLower = less leverage
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DOC
DOC
UVE
UVE
Q1 26
$595.8M
Q4 25
$467.5M
$408.9M
Q3 25
$91.0M
$405.1M
Q2 25
$89.4M
$367.1M
Q1 25
$70.6M
$398.2M
Q4 24
$119.8M
$259.4M
Q3 24
$180.4M
$333.7M
Q2 24
$106.9M
$283.3M
Total Debt
DOC
DOC
UVE
UVE
Q1 26
Q4 25
$9.8B
$100.5M
Q3 25
$9.1B
$100.7M
Q2 25
$9.0B
$100.9M
Q1 25
$8.9B
$101.1M
Q4 24
$8.7B
$101.2M
Q3 24
$8.6B
$101.4M
Q2 24
$8.6B
$101.6M
Stockholders' Equity
DOC
DOC
UVE
UVE
Q1 26
$584.7M
Q4 25
$7.5B
$551.0M
Q3 25
$7.6B
$495.0M
Q2 25
$7.9B
$457.8M
Q1 25
$8.2B
$422.4M
Q4 24
$8.4B
$373.3M
Q3 24
$8.6B
$400.2M
Q2 24
$8.8B
$393.2M
Total Assets
DOC
DOC
UVE
UVE
Q1 26
$2.8B
Q4 25
$20.3B
$2.8B
Q3 25
$19.6B
$3.1B
Q2 25
$19.8B
$3.3B
Q1 25
$19.8B
$2.7B
Q4 24
$19.9B
$2.8B
Q3 24
$20.0B
$2.7B
Q2 24
$20.2B
$2.7B
Debt / Equity
DOC
DOC
UVE
UVE
Q1 26
Q4 25
1.31×
0.18×
Q3 25
1.20×
0.20×
Q2 25
1.14×
0.22×
Q1 25
1.08×
0.24×
Q4 24
1.04×
0.27×
Q3 24
1.00×
0.25×
Q2 24
0.98×
0.26×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DOC
DOC
UVE
UVE
Operating Cash FlowLast quarter
$1.3B
Free Cash FlowOCF − Capex
$357.0M
FCF MarginFCF / Revenue
49.6%
Capex IntensityCapex / Revenue
124.4%
Cash ConversionOCF / Net Profit
10.99×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DOC
DOC
UVE
UVE
Q1 26
Q4 25
$1.3B
$381.5M
Q3 25
$315.0M
$62.4M
Q2 25
$363.5M
$106.2M
Q1 25
$279.4M
$186.8M
Q4 24
$1.1B
$137.4M
Q3 24
$318.2M
$82.6M
Q2 24
$316.2M
$73.2M
Free Cash Flow
DOC
DOC
UVE
UVE
Q1 26
Q4 25
$357.0M
$377.1M
Q3 25
$61.3M
Q2 25
$105.2M
Q1 25
$185.5M
Q4 24
$333.7M
$130.0M
Q3 24
$81.0M
Q2 24
$71.6M
FCF Margin
DOC
DOC
UVE
UVE
Q1 26
Q4 25
49.6%
92.4%
Q3 25
15.3%
Q2 25
26.3%
Q1 25
47.0%
Q4 24
47.8%
33.8%
Q3 24
20.9%
Q2 24
18.8%
Capex Intensity
DOC
DOC
UVE
UVE
Q1 26
Q4 25
124.4%
1.1%
Q3 25
0.3%
Q2 25
0.2%
Q1 25
0.3%
Q4 24
105.6%
1.9%
Q3 24
0.4%
Q2 24
0.4%
Cash Conversion
DOC
DOC
UVE
UVE
Q1 26
Q4 25
10.99×
5.73×
Q3 25
1.57×
Q2 25
11.48×
3.03×
Q1 25
6.52×
4.51×
Q4 24
235.43×
22.82×
Q3 24
3.71×
Q2 24
2.17×
2.07×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons